Previous studies have revealed that histone acetyltransferase p300 is recruited to the promoters of certain cardiac and smooth muscle specific genes to enhance the transactivation activity of myocardin, which is a master regulator in cardiovascular differentiation and development. Here, we found that the gene encoding catechol-O-methyltransferase (COMT), an important metabolic enzyme catalyzing the conversion of estrogen, is also a target gene of myocardin-related transcription factors (MRTFs). Megakaryoblastic leukemia 1 (MKL1, also named MRTF-A) and p300 could synergistically augment the expression of COMT gene, increase the metabolic rate of estrogen, and thus reduce the proliferation of MCF-7 breast cancer cells stimulated by estrogen.
Introduction
Breast cancer is a common cancer diagnosed in women in the world. Abundant experimental and epidemiological evidence has demonstrated that estrogen is a prime risk factor for the development of breast cancer [1] [2] [3] [4] . However, the exact role of estrogen in carcinogenesis is still unclear. In recent years, the relationship between the metabolic process of estrogen and breast cancer is widely studied [5] . The oxidation of catechol estrogens to semiquinones and quinones promotes DNA oxidation and adduct formation, while COMT, a well-known catecholamine methyltransferase, can prevent this kind of DNA damage by inactivating catechol estrogens [6, 7] . Accumulating evidence has confirmed that in addition to converting detrimental 4-hydroxyestradiol into water-soluble 4-methoxyestradiol to decrease the probability of forming quinone structure, COMT can also catalyze the conversion of 2-hydroxyestradiol to 2-methoxyestradiol which has anti-cancer activities. Furthermore, COMT is widely expressed in human organs, and has higher levels in endometrium and mammary gland. Therefore, estradiol metabolism mediated by COMT might be an important detoxification pathway in the estrogen-related organs such as breast and uterus. Previous studies have also reported that the aberrant COMT activity in tissues is associated with the development and progression of breast cancer and endometrial cancer [8] . Therefore, it is proposed that estradiol metabolism mediated by COMT may be an important detoxification pathway in the estrogen-related organs, and be closely related to breast cancer and cervical cancer.
Myocardin-related transcription factors (MRTFs) including myocardin, MRTF-A/MKL1/MAL, and MRTF-B/MKL2, comprise a family of transcriptional co-activators of serum response factor (SRF) and are necessary for the expression of cardiac and smooth muscle genes, immediate early genes, and cytoskeletal genes. MRTFs activate transcription through direct interaction with the ubiquitous transcription factor SRF, which binds to a responsive element CC(A/T) 6 GG (known as CArG box) in the promoters of target genes [9, 10] .
The acetylation of histones in the promoter region is believed to be a key step in transcription initiation [11, 12] . p300 and CREB-binding protein are the best-characterized histone acetyltransferases (HATs) which act as bridging factors between transcription factors and other components of the transcriptional machinery, and are targets for several intracellular signaling pathways which stimulate transcription [13] . Previous studies have shown that p300 can directly interact with myocardin, and consequently induce the acetylation of myocardin and nucleosomal histones surrounding SRF-binding sites. Acetylation of both histone and myocardin by p300 can enhance the expression of promyogenic gene in cardiac and smooth muscle cells [13, 14] .
By using bioinformatics analysis, we have found that a CArG box is present in the promoter of COMT gene, indicating that COMT gene might be a transcriptional target of MRTFs [9] . Since megakaryoblastic leukemia 1 (MKL1) has been reported as a key regulator of mammary gland function, and can directly inhibit estrogen receptor a (ERa) signal transduction [10, 15] , we wondered whether MKL1 and p300 could synergistically enhance the transcription and expression of COMT and finally reduce the risk of breast cancer. To address this issue, the present study was performed. Our results showed that p300 augmented the transcriptional activity of MKL1 on COMT gene. MKL1 and p300 could collaboratively accelerate the metabolism of 17b-estradiol (E 2 ) and reduce the proliferation-promoting effect of E 2 in MCF-7 breast cancer cells.
Materials and Methods
Reagents Anacardic acid (AnAc), an HAT inhibitor, and E 2 were all purchased from Sigma-Aldrich (St Louis, USA) and dissolved in ethanol for use.
Cell lines and transfection
African green monkey kidney fibroblast cell line COS7 and human breast cancer cell line MCF-7 were preserved in the Key Laboratory of Industrial Microbiology of the Ministry of Education (Tianjin, China). All the cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% of fetal bovine serum at 378C in a humidified incubator with 5% CO 2 . Transient transfection was carried out with TurboFect reagent (Thermo, Hudson, USA) according to manufacturer's instruction. Empty plasmid was cotransfected to normalize the transfection efficiency.
Construction of COMT promoter luciferase reporter plasmid The COMT promoter was amplified by polymerase chain reaction (PCR) using the genomic DNA isolated from MCF-7 cells as template. The following primers were used in PCR: 5 0 -CGCGGTACCACATCCGTGATTCTGAAC-3 0 (forward) and 5 0 -TAACTCGAGACGACGATGGCGGCA ATG-3 0 (reverse). PCR was performed as follows: 958C for 5 min, then 30 cycles of 958C for 45 s, 62.88C for 45 s, and 728C for 2 min; and 728C for 10 min. The PCR products (1216 bp) were double-digested with KpnI and HindIII (Thermo) and inserted into the pGL3 basic luciferase reporter vector (Promega, Madison, USA). The correct construction, named pGL3-COMT, was confirmed by restriction enzyme digestion and sequencing. The CArG box in the promoter was mutated by the method of site-directed mutagenesis with following primers: 5 0 -TTTGATGCCGA ATCCCCgggTATGGGACTCCGCCA-3 0 (forward) and 5 0 -TGGCGGAGTCCCATAcccGGGGATTCGGCATCAAA-3 0 (reverse). PCR was performed as follows: 958C for 5 min, then 30 cycles of 958C for 45 s, 54.88C for 45 s, and 728C for 7 min; and 728C for 10 min. The PCR products were digested with DpnI (Thermo) and transformed into Escherichia coli DH5a. The correct construction, was confirmed by restriction enzyme digestion and sequencing.
Luciferase assay COS7 cells were transfected with different concentration of plasmids, and treated with AnAc at 6 h post-transfection. Twenty-four hours later, cells were lysed and whole cell extracts were prepared and analyzed by using the Luciferase Assay System (Promega) according to manufacturer's instruction. Protein concentration of whole cell extracts was determined with the BCA protein assay kit (Thermo). Luminescence was measured and normalized by using a Synergy4 microplate reader (BioTek, Winooski, USA).
RNA isolation and reverse transcription-PCR
MCF-7 cells were plated into six-well plates at a density of 4 Â 10 4 cells per well. Six hours after transfection, cells were treated with 5 M AnAc or ethanol alone for 24 h. Total RNA was then isolated by using Trizol reagent (Invitrogen, Carlsbad, USA). First-strand cDNA was synthesized with random hexamer primers. PCR primers specific for MKL1, p300, COMT, or GAPDH, the internal control, were listed in Table 1 . PCR was performed as follows: 958C for 5 min, then 30 cycles of 958C for 45 s, 628C (MKL1), 58.78C ( p300), 57.68C (COMT), or 548C (GAPDH) for 45 s, and 728C for 45 s; 728C for 10 min. PCR products were electrophoretically separated on 1.5% agarose gels and visualized by ethidium bromide staining. The densities of the bands were analyzed by using Quantity One software (v4.31, Bio-Rad, Hercules, USA) and data were expressed as relative expression levels normalized by using GAPDH. All experiments were performed in duplicates or triplicates and repeated three times.
Immunofluorescence MCF-7 cells grown in 24-well plate at a density of 6 Â 10 were stained with fluorescent secondary antibodies (fluorescein isothiocyanate, goat anti-rabbit IgG, 1 : 150, ZF-0311; Jackson, West Grove, USA) and 40-6-diamidino-2-phenylindole in PBS for 30 min at room temperature and finally examined under an Olympus FV1000 inverted confocal microscope (Olympus, Tokyo, Japan).
Western blotting
After washing with ice-cold PBS twice, the cells were lysed at 48C with RIPA lysis buffer containing protease inhibitors. The lysates were centrifuged at 10,000Â g for 10 min and then the supernatants were mixed with sodium dodecyl sulfate (SDS) sample buffer. The soluble proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blotted with primary antibodies against COMT (Proteintech), myc (Proteintech), HA (Proteintech), and b-actin (Santa Cruz, Santa Cruz, USA) at appropriate dilutions (1 : 500, 1 : 1000, 1 : 1000, 1 : 500). Infrared-stained secondary antibodies (IRDye w 680RD, goat anti-rabbit, 926-68071; IRDye w 800CW, goat anti-mouse, 926-32210; LI-COR, Lincoln, USA) were incubated with the membrane at a dilution of 1 : 10,000. The signals were then visualized by using Odyssey w Imaging System (LI-COR).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was performed by using SimpleChip w Enzymatic Chromatin IP Kit (Cell Signaling Technology, Danvers, USA). In brief, 4 Â 10 6 MCF-7 cells grown in 15 cm culture dishes were transfected. Forty-eight hours later, cells were cross-linked by formaldehyde (1% for 10 min) and then collected. After digestion with micrococcal nuclease and sonication, chromatin was sheared into 200-1000 bp length. Two percent supernatant was used as input control for PCR and the residual samples were immunoprecipitated with 5 mg anti-myc and anti-flag antibody, respectively. The protein-antibody complexes were recovered on protein G beads. Immunoprecipitates were washed under stringent conditions, and cross-links of chromatin were reversed by incubating samples overnight at 658C. The resultant DNA was purified and analyzed by using PCR. The following primer pairs were used for each indicated promoter: CArG, 5
0 -CTGTC TGTTGTCCCCACTAC-3 0 and 5 0 -CCAGGGCACTCCATC TTTC-3 0 , 195 bp; Control, 5 0 -GCGTTGTCGTAAGGG TA-3 0 and 5 0 -CCATCTGGATTGGCTGTA-3 0 , 220 bp.
Liquid chromatography-tandem mass spectrometry analysis of E 2 MCF-7 cells were transfected with MKL1 and p300 for 6 h, then the medium was replaced with fresh serum-free medium containing 10 26 M E 2 . Forty-eight hours post-E 2 treatment, the concentration of residual E 2 in cell culture medium was detected by using liquid chromatographytandem mass spectrometry (LC-MS/MS) (Agilent ZORBAX XDB-C18, 0.4 ml/min) system (ABI-4000 Biosystem; ABI, New York, USA).
Proliferation assay
Cell proliferation was measured by using MTT assay. In brief, 5 Â 10 3 MCF-7 cells were seeded in 96-well tissue culture plates and transfected with MKL1 and p300-encoding plasmids. Six hours later, cell culture medium was replaced with fresh serum-free medium containing 10
28 M E 2 or ethanol. Forty-eight hours post-E 2 treatment, medium in each well was replaced by 100 ml of fresh serum-free medium containing 1 mg/ml MTT. After incubation at 378C for 4 h, the MTT-containing medium was removed and 50 ml of dimethyl sulfoxide was added into each well. After incubation at 378C for another 10 min, the absorbance value of each well was measured by using Synergy4 Microplate Reader at a wavelength of 490 nm. The cell proliferation rate was calculated from absorbance by the formula of [A E2(þ) 2A E2 (2) ]/A E2(2) . Fig. 2(A,B) . b Optimum temperature used in PCR.
p300 promotes MKL1-mediated transactivation of COMT gene
Results
Transactivation effect of MKL1 on COMT promoter was suppressed by HAT inhibitor Bioinformatics analysis showed that one CArG box was present in the 21069 promoter of COMT [ Fig. 1(A) ]. To test the transactivation effects of MKL1 on this COMT promoter, COS7 cells were transfected with COMT promoter luciferase constructs combined with 0.2, 0.4, 0.6, or 0.8 mg of MKL1 expression plasmids. As shown in Fig. 1(B) , overexpressed MKL1 increased the promoter activity of COMT in a dose-dependent manner. Furthermore, we investigated the effects of the HAT inhibitor AnAc on the MKL1-stimulated COMT promoter activation. The result showed that AnAc significantly reduced the transcriptional activation of MKL1 on the COMT promoter [ Fig. 1(C) ]. These results suggested that MKL1 was able to enhance the transcription of COMT gene, and HATs might play a positive role in this process.
p300 enhanced the transcriptional activity of MKL1 on COMT To further determine whether p300, the most ubiquitous HAT, modulates the transactivation activity of MKL1 on RT-PCR analysis showed that the mRNA level of COMT in cells cotransfected with MKL1 and p300 was significantly higher than that in mock-transfected cells [ Fig. 2(A,C) ], whereas the up-regulation of COMT induced by MKL1 and p300 was diminished by AnAc treatment [ Fig. 2(B,D) ]. Consistent with the results of RT-PCR analysis, remarkable increase of protein level of COMT in the MKL1/p300 cotransfection group was also observed in western blotting and immunofluorescence analysis, while it remained unchanged when cells were additionally treated with AnAc (Fig. 3) . These results suggested that p300 might be required for MKL1-induced activation of COMT gene in MCF-7 cells.
Transactivation of COMT induced by MKL1 and p300 was mediated via MKL1-SRF-CArG-box signal transduction To examine the effects of MKL1 and p300 on COMT promoter, the reporter assays were performed. As shown in Fig. 4(A,B) , consistent with the results of protein expression, the transcriptional activity of COMT promoter was cooperatively increased by MKL1 and p300 in either COS7 or MCF-7 cells. As is well known, MRTFs can strongly activate CArG-box-containing promoters through its direct binding to SRF. To understand the mechanism underlying how MKL1 and p300 mediated the regulation of COMT transcriptional activity, we mutated the CArG box presented in the COMT promoter by using site-directed mutagenesis.
As we expected, compared with control, the luciferase p300 promotes MKL1-mediated transactivation of COMT gene activity was significantly reduced when CArG box was mutated. Based on these results, we suspected that the active effects of COMT transcriptional activity mediated by MKL1 and p300 might be due to MKL1-SRF-CArG-box signal transduction. To further confirm this hypothesis, ChIP assay was carried out. MCF-7 cells were transfected with fulllength myc-MKL1, or combined with p300. The primers encompassing the CArG box (CArG primers), the negative primers (control primers) in the COMT promoter, and unrelated GAPDH primers were used for PCR amplification [ Fig. 4(C) ]. As shown in Fig. 4(D) , there was a clear band amplified by CArG primers in the group transfected with MKL1, indicating that MKL1 could directly bind to the CArG box region of COMT promoter. This specific interaction was verified by the absence of specific sequence amplifications when the omission of antibodies was applied, or when primers for control and unrelated GAPDH gene were used in the PCR reaction. Furthermore, when MKL1 was suppressed by short hairpin (shRNA) (a gift from Sobue and coworkers [16] ), the MKL1/p300-induced transactivation of COMT was blocked significantly (Fig. 5) . Taken together, our results suggested that MKL1 was essential for the up-regulation of COMT by MKL1 and p300, while p300 acted as a synergist in this event.
MKL1 and p300 promoted metabolic rate of E 2 Several enzymes including CYP1A1, CYP1B1, COMT, and GST pi are involved in the E 2 metabolic pathway.
In the mammary gland, the methylation of 2-and 4-hydroxyestradiol ( primary metabolic products of E 2 ) to generate 2-or 4-methoxyestradiol is mainly catalyzed by COMT protein [17] . In the above section, we found that MKL1 and p300 synergistically induced the up-regulation of COMT. However, it was still necessary to determine whether the metabolic rate of E 2 can also be enhanced following the increased production of the enzyme. For this purpose, LC-MS/MS analysis was performed. As shown in Fig. 6(B) , the concentrations of residual E 2 in transfection groups were all decreased, and in particular, when compared with control group, the E 2 metabolic rate in the cotransfection group was the lowest among all the groups. In contrast, these metabolism-promoting effects were also suppressed by AnAc, suggesting that MKL1 and p300 could synergistically enhance the expression of COMT and thereby promote the metabolism of E 2 .
MKL1 and p300 inhibited E 2 -induced proliferation of MCF-7 cells Finally, MTT assay was carried out to examine whether the up-regulation of COMT by MKL1 and p300 can inhibit E 2 -induced proliferation of MCF-7 breast cancer cells. Consistent with the findings described above, this result also showed that the proliferation-stimulating activity of E 2 was significantly decreased in the MKL1/p300-cotransfected group [ Fig. 6(C) ], suggesting that MKL1 and p300 could synergistically suppress cell proliferation stimulated by estrogen via accelerating estrogen metabolism. Analysis for the association of MKL1 and p300 with CArG box in COMT promoter by ChIP assay. DNA from MCF-7 cells transfected with myc-tagged MKL1 and/or p300 was immunoprecipitated by using anti-myc antibodies, and analyzed by PCR using primer pairs covering the specified regions of CArG (CArG primer), negative regions (Control primer) which are far away from CArG site or unrelated GAPDH.
Discussion
The importance of estrogen for development of mammary gland was recognized several decades ago and has been unequivocally confirmed. Now, it is widely accepted that estrogen is important for not only mammogenesis, but also women involution. Some recent findings have specially emphasized that estrogen and estrogen-like compounds are involved in various physiological and pathological processes. In addition, several studies have indicated that the estrogen-metabolic enzyme, COMT, is associated with the breast cancer risk. However, the biological mechanism is currently unknown. Here, we showed that MKL1, a co-activator of SRF, could active the expression of COMT gene via recruiting p300, and thereby accelerate the metabolism of estradiol and consequently inhibit the effects of estrogen on proliferation of ER-positive breast cancer cell lines. MKL1 is a member of MRTFs, which are key regulators in smooth muscle differentiation and cardiovascular development. Unlike myocardin, which is specifically expressed in cardiac and smooth muscle cells, MKL1 is expressed in a broad range of cell types and has more extensive transactivating functions than myocardin [18] . It has been reported that estrogen can affect vascular reactivity and endothelial cell function [19] [20] [21] [22] , and the metabolizing function of COMT within the coronary artery might be an important determinative of the cardiovascular protective effects of circulating estrogen. Some reports also showed that COMT can regulate the cellular estrogenic milieu through controlling Figure 5 Suppression of MKL1 by RNAi blocked the synergistic transactivation effect of MKL1/p300 on COMT gene (A) COS7 cells were transfected with MKL1, p300, and COMT reporter construct and the reporter assay were performed. MKL1 and p300 could cooperatively drive the COMT promoter (white column) and this effect was reduced after cotransfection with MKL1 shRNA (black column). (B) The same experiments were also performed in MCF-7 cells. (C,D) Immunofluorescence assay for the transactivation effects of MKL1 and p300 on COMT. MCF-7 cells expressing MKL1 and p300 were fixed and analyzed by using anti-COMT antibody (green). MKL1 and p300 could collaboratively increase the expression of COMT (C), whereas this promotion could be blocked by MKL1 shRNA (D). p300 promotes MKL1-mediated transactivation of COMT gene the concentration of estrogen metabolites in human myometrial cells [23] . In addition, Huet et al. [15] found that the activation of the Rho/Actin/MKL1 signaling pathway can impair ERa-dependent transcriptional activation, and this function is mainly through the direct inhibition of the AF1 domain of ERa. Taken together, our findings suggested that there is a close relationship among MRTFs, COMT, and estrogen in breast cancer and cardiovascular development. Except for the direct inhibitory effect of MKL1 on the ERa transcriptional activity, the accelerated E 2 metabolism mediated by COMT up-regulation might also contribute to the repression effects of MKL1 on E 2 /ER signal pathway.
HATs are enzymes that acetylate conserved lysine residues in histone proteins by transferring an acetyl group from acetyl CoA to form 1-N-acetyl lysine [24] . Histone acetylation plays an important role in regulating the chromatin structure and is generally linked to transcriptional activation. Cao et al. [14] have showed that except for acetylating histones, p300 could also interact directly with myocardin and acetylate the associator to enhance the transcriptional activating function. In addition, they found that both histone acetylation on promoter region and acetylation of N-terminus of the myocardin protein were required for the activation of cardiac and smooth muscle genes. Similar to this report, our present study demonstrated that p300 could also promote the transcriptional activity of MKL1 on COMT gene.
Furthermore, we first reported that MKL1 and p300 synergistically play a critical role in inhibiting the cell proliferation-promoting effect of estrogen on ER-positive breast cancer cells. These novel findings might inspire better solutions for diseases associated with estrogen disorder (such as breast cancer, osteoporosis, etc.) and some other metabolic diseases, or cardiovascular diseases in the future. 
